Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia
Clinical trial NCT07288333 · RECRUITING
Trial details
- NCT number
- NCT07288333
- Sponsor
- Neurocrine Biosciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-16
- Primary completion
- 2027-08-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.